Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
2,13,15 The occurrence of GI AEs associated with GLP-1 RAs is well established, but direct comparisons of incidence and severity across individual agents are less consistently reported
Because of this, your clinician might suggest waiting before evaluating results, so the medication has time to reach its full effect
23 These symptoms can be severe in some patients, resulting in a pause of dose escalation, and if intolerable GI symptoms continue, a dose adjustment to the previous lower dose or a switch to an alternative GLP-1 RA should be considered
Metabolism & Elimination GLP2 undergoes metabolism through pathways typical of peptide therapeutics: Plasma half-life of approximately 5 days in humans, enabling once-weekly administration Primary metabolic pathways include proteolytic cleavage of the peptide backbone, beta-oxidation of the C20 fatty diacid moiety, and amide hydrolysis Not metabolized via cytochrome P450 enzymes, sulfation, or glucuronidation pathways Low potential for drug-drug interactions mediated through hepatic metabolism or transporter systems The extended half-life represents a key pharmacokinetic advantage, with steady-state accumulation of approximately 1.7-fold enabling consistent therapeutic exposure throughout the dosing interval
#medicine #medical #clinical #hospital #pharmacy #patient #care #mtm #linkedin #healthcare #medications To view or add a comment, sign in 10,577 followers
Examples include Greek yogurt with berries, cottage cheese toast, egg bites with fruit, or a protein smoothie
